Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

计划入组 250 人 · 首次发布于 2019 年 5 月 22 日

Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer

计划入组 24 人 · 首次发布于 2025 年 1 月 9 日

Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer

计划入组 77 人 · 首次发布于 2019 年 1 月 28 日

JS-001 + albumin-bound paclitaxel

Albumin-bound-paclitaxel/JO-1

Sirolimus Albumin-Bound

SAVIOR LIFETEC CORPORATION TAINAN BRANCH INJECTION PLANT

Taiwan

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

CSPC Wins China NMPA Approval for World's First Fast-Dissolving Albumin-Bound Paclitaxel in Metastatic Breast Cancer

Nab-Paclitaxel Plus Carboplatin Shows Promise in Advanced Ovarian Cancer

Sandoz Launches Generic Paclitaxel for Metastatic Breast Cancer Treatment